Print Page   |   Sign In   |   Become a Member
Other Awards



HTRS Awards

Check here for updates on HTRS awards.

THSNA Travel-To-A-Mentor Award Call for Applications

Deadline January 8, 2018
Each THSNA Travel-To-A-Mentor Award provides financial support (up to $2,500 per award) for one mentee to train for one week with a pre-selected research mentor at the mentor's facility anywhere in the US, Canada, or Mexico. Award funds will cover transportation, hotel/housing, meals, and essential incidental expenses.

Applicants must be a member of a  THSNA member organization.  HTRS is a member of THSNA.

The structure of each one-week experience will be determined jointly by the mentee and mentor, and is expected to include: 

a) clinical and/or laboratory experiences (where applicable)
b) Attendances at relevant conferences and laboratory or research group meetings
c) A meeting with the mentor to discuss potential future collaborations

Awards will fall into the following categories:

  • Nursing
  • Laboratory technologist/specialist
  • Pharmacist
  • PhD researcher
  • Physician investigator, clinical, translational, or basic
  • Patient advocate

Please find below the link to the complete Award Outline and Application Link.
http://thsna.org/web/mentor/

The next application deadline is  Monday, January 8, 2018.

For questions or assistance with locating a mentor, please contact THSNA at:
Phone: 847.978.2001
Email: info@thsna.org

New and Launching Funding Opportunity

NHLBI’s Division of Blood Diseases and Resources is pleased to announce a recently published Funding Opportunity Announcements (FOAs) as well as the following FOAs soon to be published in the spring or summer of 2017.

 

FOA -  Center for the Investigation of Factor VIII (FVIII) Immune Response in Patients with Hemophilia A (U54)

A new Funding Opportunity Announcement (FOA) from the National Heart, Lung, and Blood Institute (NHLBI) entitled “Center for the Investigation of Factor VIII (FVIII) Immune Response in Patients with Hemophilia A (U54)” is currently available. RFA-HL-18-014 provides funding for up to four Centers to define the basic mechanisms involved in the development of anti-FVIII neutralizing antibodies, also known as inhibitors, in patients with hemophilia A. These Centers will utilize cross-disciplinary scientific fields together with novel technologies to make breakthrough advances that could translate into successful strategies to prevent and/or suppress inhibitor formation in this patient population. Applications will also include a Skills Development component to support the development of interdisciplinary research skills and expertise in the blood sciences.
For more information about these grants.